Notice: Prescription Drug List (PDL): Hyoscine butylbromide

Name: Notice: Prescription Drug List (PDL): Hyoscine butylbromide
Creator: Health Canada
License: https://open.canada.ca/en/open-government-licence-canada

The purpose of this Notice of Amendment is to notify that Health Canada will switch injectable Hyoscine butylbromide to prescription status from ethical status for human use by adding it to the Human Prescription Drug List (PDL). Injectable Hyoscine butylbromide is already listed on the Veterinary Prescription Drug List.

Publisher: Health Canada
Resources: 2
Catalogue metadata updated: 2023-09-30

Data overview

Formats: HTML
File languages: English, French

Official sources and licences

Government of Canada Open Data
Open Government Licence – Canada

Resources

Notice: Prescription Drug List (PDL): Hyoscine butylbromide (French, HTML) HTML
Notice: Prescription Drug List (PDL): Hyoscine butylbromide (English, HTML) HTML

Related open data

Health Canada